Effect of pulsing magnetic fields therapy on multiple sclerosis fatigue and selected features of quality of life
Keywords:
multiple sclerosis, fatigue, quality of life, pulsing magnetic fieldsAbstract
Aim of this study: Fatigue is common in multiple sclerosis (MS). In the recent years there have been numerous rapports concerning utilization of magnetostimulation in treatment of this conventional methods-proof complication. The aim of the research was to evaluate the impact of pulsing magnetic fields generated by magnetostimulator on the level of fatigue and selected aspects of MS patients’ quality of life.
Materials and methods: The research was conducted amongst 48 people with clinically definite MS, experiencing intensive fatigue. The duration of the disease was on average 8.5±5,6 years, and the average age of the patients was 41.8 ±9,2 years. The patients were divided randomly into two groups: the control group and the examined group. The examined group was treated with magnetic field generated by magnetostimulator, while the control group was treated with the device with option of a placebo. The procedures were performed 2 times a day for 6 weeks. In the beginning and after 3 and 6 weeks there was an evaluation of levels of: disability with Expanded Disability Status Scale(EDSS), fatigue with Fatigue Severity Scale (FSS) and Modified Fatigue Impact Scale (MFIS), depression with Beck Depression Inventory (BDE) and the quality of life with Functional Assessment of Multiple Sclerosis (FAMS).
Results: There was a significant decrease of fatigue after 6 weeks in the group treated with magnetic field in comparison to the placebo group, both in the FFS (4,1 versus 5,1) and the MFIS (28,22 v. 39.61). The main differences concerned the physical (p = 0.0018) and cognitive (p = 0.035) aspect of fatigue. People treated with magnetic field after 6 week also declared a better quality of life (124,3 ± 15,6 versus 96,8 ± 15,2), as evaluated by FAMS questionnaire. The evaluation in the EDSS scale did not showed any improvement of motor ability in both groups.
Conclusions: Magnetostimulation significantly decreases the level of fatigue in multiple sclerosis and positively influences some aspects of MS patients’ quality of life (emotional state, content of life, thinking and fatigue). It may prove itself as an alternative method of symptomatic treatment of MS patients.
Downloads
References
Selmaj K.: Stwardnienie rozsiane, Termedia Wydawnictwo Medyczne, Poznań 2006.
Brola W, Ziomek M, Czernicki J.: Zespół zmęczenia w przewlekłych chorobach neurologicznych, Neur Neurochir Pol 2007; 41:340–349.
Dworzańska E, Mitosek-Szewczyk K, Stelmasiak Z.: Zespół zmęczenia w stwardnieniu rozsianym, Neurol Neurochir Pol. 2009;43:71–6.
Geisler MW, Sliwinski M, Coyle PK i wsp.: The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis, Arch Neurol 1996;53:185 – 188.
Stein DP, Dambrosia JM, Dalakas MC.: A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the postpolio syndrome, Ann N Y Acad Sci 1995;753: 296–302.
Kraft GH, Bowen J, Stankoff B. i wsp. Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study, Neurology 2005; 65:1995–1997.
Willoughby E.: Modafinil for fatigue in multiple sclerosis J Neurol Neurosurg Psychiatry 2002;72: 150–150.
Zifko UA, Rupp M, Schwarz S. i wsp.: Modafinil in treatment of fatigue in multiple sclerosis: results of an open-label study, J Neurol 2002; 249: 983–87.
Stankoff B, Waubant E, Confavreux C. i wsp.: Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study, Neurology 2005;64:1139–1143.
Branas P, Jordan R, Fry-Smith A. i wsp.: Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol Assess 2000; 4:1–61.
Richards TL.: Double-blind study of pulsing magnetic field effects on multiple sclerosis. J Altern Complement Med 1997; 3: 21–29
Lappin MS, Lawrie FW, Richards TL, Kramer ED.: Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double-blind, placebo controlled trial, Altern Ther Health Med. 2003; 9: 38–48.
Piatkowski J, Kern S, Ziemssen T.: Effect of BEMER magnetic field therapy on the level of fatigue In patients with multiple sclerosis: A randomized, double-blind controlled trial. J Altern Complement Med 2009; 15: 507–511.
Kurtzke J.: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.
Opara J, Jaracz K, Brola W.: Aktualne możliwości oceny jakości życia w stwardnieniu rozsianym, Neur Neurochir Pol 2006;40:336 – 341.
Sieroń A, Cieślar G, Kawczyk-Krupka A i wsp.: Zastosowanie pól magnetycznych w medycynie. Wyd. II uzupełnione i rozszerzone. a-medica press, Bielsko-Biała 2002.
Jamroz-Wiśniewska A, Papuć E, Bartosik-Psujek H, Belniak E, Mitosek-Szewczyk K, Stelmasiak Z.: Analiza walidacyjna wybranych aspektów psychometrycznych polskiej wersji Skali Wpływu Zmęczenia Stwardnienia Rozsianego na jakość życia chorych (MSIS-29). Neurol Neurochir Pol. 2007;41:215–22.
Cella DF, Dineen K, Arnason B, Reder A, Webster KA, Karabatsos G i wsp.: Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996; 47: 129–39.
Kossakowska M.: Standaryzacja polskiej wersji Kwestionariusza do Oceny Jakości Życia w Stwardnieniu Rozsianym (FAMS). Psychologia Jakości Życia 2004; 3: 65–80.
Brola W., Węgrzyn W., Czernicki J.: Wpływ zmiennego pola magnetycznego na niewydolność ruchową i jakość życia chorych ze stwardnieniem rozsianym. Wiad Lek 2002, 55, nr 3–4: 136.
Sieroń A, Cieślar G, Matuszczyk J, Żmudziński J.: Próba wykorzystania zmiennego pola magnetycznego w objawowym leczeniu stwardnienia rozsianego, Pol Tyg Lek 1996; 51: 113–115.
Nielsen JF, Sinkjear T, Jakobsen J.: Treatment of spasticity with repetitive magnetic stimulation: a double-blind placebo-controlled study, Mult Scler 1996; 2: 227–32.
Sandyk R.: Successful treatment of multiple sclerosis with magnetic fields. Int J Neurosci 1992;66:237–250.
Sandyk R, Iacano RP.: Resolution of longstanding symptoms of multiple sclerosis by application of picoTesla range magnetic fields. Int J Neurosci 1993; 70: 255–269.
Sandyk R.: Progressive cognitive improvement in multiple sclerosis from treatment with electromagnetic fields. Int J Neurosci 1997; 89: 39–51.
Mostert S, Kesselring J.: Effect of pulsed magnetic field therapy on the level of fatigue in patients with multiple sclerosis. A randomized controlled trial, Multiple Sclerosis 2005;11:302–305.
Neill J, Belan I, Ried K.: Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: A systemic review. J Adv Nurs 2006;56:617–635.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2010 Medical Journal of the Rzeszow University
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
